North America / UNITED STATES
Company Overview
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | UNITED STATES |
| Employees | 778 |
| Reporting Unit | Millions |
| Primary Exchange | NYSE NAS ASE DUS FRA LON |
| Instrument Type | Equity |
| Website | http://www.supernus.com |
| Wright ID | C840FMB9K |
Key Metrics
| Current price | $28.15 |
| Market cap | $1.64 B |
| P/E ratio | n/a |
| 52-week perf. | -49.5% |
| Common shares | 58.2 M |
| Closely held | 3.1 M |
| Share type | Common |
| Quality rating | BAD0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | -32.9% |
| 4 Week | -33.6% |
| 13 Week | -38.8% |
Officers
| Non Executive Chairman | Charles W. Newhall III |
| President, Chief Executive & Secretary | Jack A. Khattar |
| Senior Vice President & Chief Financial Officer | Timothy C. Dec |
Address
9715 Key West Avenue
ROCKVILLE, MD
UNITED STATES
20850
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.